• Publications
  • Influence
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
Results from a European multicentre case-control study reported by Marta Valenciano and colleagues suggest good protection by the pandemic monovalent H1N1 vaccine against pH1N1 and no effect of theExpand
  • 175
  • 9
  • PDF
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
Within the Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) project we conducted a multicentre case–control study in eight European Union (EU) Member States to estimate the 2011/12Expand
  • 163
  • 8
  • PDF
I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe
Background In the third season of I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe), we undertook a multicentre case-control study based on sentinel practitioner surveillance networks inExpand
  • 115
  • 4
  • PDF
"I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9.
Within I-MOVE (European programme to monitor seasonal and pandemic influenza vaccine effectiveness (IVE)) five countries conducted IVE pilot case-control studies in 2008-9. One hundred and sixtyExpand
  • 79
  • 3
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
Since the 2008/9 influenza season, the I-MOVE multicentre case-control study measures influenza vaccine effectiveness (VE) against medically-attended influenza-like-illness (ILI) laboratory confirmedExpand
  • 83
  • 2
  • PDF
Health risk factors and mortality in Pécs City, Hungary in the 1990s.
In the period of 1990-1994 an increase of all causes mortality for 35-74 years old males was observed both in Pécs and in all Hungary. From 1994 to 1997 the mortality decreased. Similar changes, butExpand
  • 7
Early Phase of the COVID-19 Outbreak in Hungary and Post-Lockdown Scenarios
COVID-19 epidemic has been suppressed in Hungary due to timely non-pharmaceutical interventions, prompting a considerable reduction in the number of contacts and transmission of the virus. ThisExpand
Case-control study to measure influenza vaccine effectiveness during the 2008-2009, 2009-2010 and 2010-11 influenza seasons in Hungary
Resulting from the constant evolution of influenza viruses, influenza vaccine effectiveness can vary from year to year depending on the matching between the circulating strains and the ones that areExpand
Eurosurveillance, Volume 18, Issue 5, 31 January 2013 Surveillance and outbreak reports LOW AND DECREASING VACCINE EFFECTIVENESS AGAINST INFLUENZA A(H3) IN 2011/12 AMONG VACCINATION TARGET GROUPS IN
Surveillance and outbreak reports LOW AND DECREASING VACCINE EFFECTIVENESS AGAINST INFLUENZA A(H3) IN 2011/12 AMONG VACCINATION TARGET GROUPS IN EUROPE: RESULTS FROM THE I-MOVE MULTICENTREExpand